These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 1323141)

  • 1. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
    Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
    Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
    Werner H; Roberts CT; Rauscher FJ; LeRoith D
    J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
    Lee YI; Kim SJ
    DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
    Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
    Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
    Hamilton TB; Barilla KC; Romaniuk PJ
    Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
    Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
    J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1.
    Ward A; Pooler JA; Miyagawa K; Duarte A; Hastie ND; Caricasole A
    Gene; 1995 Dec; 167(1-2):239-43. PubMed ID: 8566784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
    Tajinda K; Carroll J; Roberts CT
    Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
    Madden SL; Cook DM; Rauscher FJ
    Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
    Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
    Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1.
    Wang ZY; Qiu QQ; Enger KT; Deuel TF
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8896-900. PubMed ID: 8415628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
    Fraizer GC; Shimamura R; Zhang X; Saunders GF
    J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.
    Haber DA; Park S; Maheswaran S; Englert C; Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Science; 1993 Dec; 262(5142):2057-9. PubMed ID: 8266105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
    Martinerie C; Chevalier G; Rauscher FJ; Perbal B
    Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression.
    Langerak AW; Williamson KA; Miyagawa K; Hagemeijer A; Versnel MA; Hastie ND
    Genes Chromosomes Cancer; 1995 Feb; 12(2):87-96. PubMed ID: 7535092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.